This HTML5 document contains 47 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
n12http://localhost/temp/predkladatel/
n4http://linked.opendata.cz/resource/domain/vavai/riv/tvurce/
n16http://linked.opendata.cz/ontology/domain/vavai/
shttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
n3http://linked.opendata.cz/ontology/domain/vavai/riv/
n8http://linked.opendata.cz/resource/domain/vavai/vysledek/RIV%2F00216208%3A11130%2F10%3A6370%21RIV11-MSM-11130___/
n2http://linked.opendata.cz/resource/domain/vavai/vysledek/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n7http://linked.opendata.cz/ontology/domain/vavai/riv/klicoveSlovo/
n17http://linked.opendata.cz/ontology/domain/vavai/riv/duvernostUdaju/
xsdhhttp://www.w3.org/2001/XMLSchema#
n14http://linked.opendata.cz/ontology/domain/vavai/riv/jazykVysledku/
n6http://linked.opendata.cz/ontology/domain/vavai/riv/aktivita/
n11http://linked.opendata.cz/ontology/domain/vavai/riv/druhVysledku/
n10http://linked.opendata.cz/ontology/domain/vavai/riv/obor/
n9http://reference.data.gov.uk/id/gregorian-year/

Statements

Subject Item
n2:RIV%2F00216208%3A11130%2F10%3A6370%21RIV11-MSM-11130___
rdf:type
skos:Concept n16:Vysledek
dcterms:description
Cutaneous T cell lymphomas other than mycosis fungoides, Sezary syndrome, and primary cutaneous CD30+ lymphoproliferations constitute less than 10% of all cutaneous T cell lymphomas. Primary cutaneous small/medium CD4+ T cell lymphoma is a member of this third group of cutaneous lymphomas, separated out as provisional entity in the World Health Organization classification - European Organization for Research and Treatment of Cancer (WHO-EORTC) classification. It still awaits development of more precise diagnostic criteria and optimal therapy. We report a case of primary cutaneous CD4 + small/medium-sized pleomorphic T cell lymphoma accompanied with myelodysplastic syndrome successfully treated with cyclophosphamide. Cutaneous T cell lymphomas other than mycosis fungoides, Sezary syndrome, and primary cutaneous CD30+ lymphoproliferations constitute less than 10% of all cutaneous T cell lymphomas. Primary cutaneous small/medium CD4+ T cell lymphoma is a member of this third group of cutaneous lymphomas, separated out as provisional entity in the World Health Organization classification - European Organization for Research and Treatment of Cancer (WHO-EORTC) classification. It still awaits development of more precise diagnostic criteria and optimal therapy. We report a case of primary cutaneous CD4 + small/medium-sized pleomorphic T cell lymphoma accompanied with myelodysplastic syndrome successfully treated with cyclophosphamide.
dcterms:title
THERAPEUTIC HOTLINE: Primary cutaneous CD4+ small/medium-sized pleomorphic T cell lymphoma coexisting with myelodysplastic syndrome transforming into chronic myelomonocytic leukemia successfully treated with cyclophosphamide THERAPEUTIC HOTLINE: Primary cutaneous CD4+ small/medium-sized pleomorphic T cell lymphoma coexisting with myelodysplastic syndrome transforming into chronic myelomonocytic leukemia successfully treated with cyclophosphamide
skos:prefLabel
THERAPEUTIC HOTLINE: Primary cutaneous CD4+ small/medium-sized pleomorphic T cell lymphoma coexisting with myelodysplastic syndrome transforming into chronic myelomonocytic leukemia successfully treated with cyclophosphamide THERAPEUTIC HOTLINE: Primary cutaneous CD4+ small/medium-sized pleomorphic T cell lymphoma coexisting with myelodysplastic syndrome transforming into chronic myelomonocytic leukemia successfully treated with cyclophosphamide
skos:notation
RIV/00216208:11130/10:6370!RIV11-MSM-11130___
n3:aktivita
n6:I
n3:aktivity
I
n3:cisloPeriodika
6
n3:dodaniDat
n9:2011
n3:domaciTvurceVysledku
n4:5791278
n3:druhVysledku
n11:J
n3:duvernostUdaju
n17:S
n3:entitaPredkladatele
n8:predkladatel
n3:idSjednocenehoVysledku
292682
n3:idVysledku
RIV/00216208:11130/10:6370
n3:jazykVysledku
n14:eng
n3:klicovaSlova
cyclophosphamide; myelodysplastic syndrome; primary cutaneous CD4+small; medium-sized pleomorphic T-cell lymphoma; who-eortc; classification
n3:klicoveSlovo
n7:classification n7:who-eortc n7:cyclophosphamide n7:myelodysplastic%20syndrome n7:primary%20cutaneous%20CD4%2Bsmall n7:medium-sized%20pleomorphic%20T-cell%20lymphoma
n3:kodStatuVydavatele
US - Spojené státy americké
n3:kontrolniKodProRIV
[DA30E68BE1ED]
n3:nazevZdroje
Dermatologic Therapy
n3:obor
n10:FO
n3:pocetDomacichTvurcuVysledku
1
n3:pocetTvurcuVysledku
8
n3:rokUplatneniVysledku
n9:2010
n3:svazekPeriodika
23
n3:tvurceVysledku
Jazienicka, Iwona Chodorowska, Grazyna Dybiec, Ewa Hercogová, Jana Wawrzycki, Bartlomiej Kowal, Malgorzata Skomra, Danuta Pietrzak, Aldona
n3:wos
000283949000010
s:issn
1396-0296
s:numberOfPages
6
n12:organizacniJednotka
11130